Fasting Hyperglycemia and Long-term Outcome in Patients with Acute Ischemic Stroke Treated with Mechanical Thrombectomy
- PMID: 32201103
- DOI: 10.1016/j.jstrokecerebrovasdis.2020.104774
Fasting Hyperglycemia and Long-term Outcome in Patients with Acute Ischemic Stroke Treated with Mechanical Thrombectomy
Abstract
Background: Little is known about the prognostic role of fasting glucose after mechanical thrombectomy (MT).
Aims: We investigated whether fasting glucose on the next day after MT was associated with long-term outcome in acute ischemic stroke patients according to diabetes.
Methods: We retrospectively analyzed 181 consecutive patients with acute anterior circulation ischemic stroke who underwent MT in 2 comprehensive stroke centers in Poland. Glucose levels were evaluated on admission and on the next day after MT. Fasting hyperglycemia (FHG) was defined as the glucose level above 5.5 mmol/L. Unfavorable outcome was defined as modified Rankin scale (mRS) of 3-6 at day 90 from stroke onset.
Results: Patients with FHG had higher mRS at 3-month follow-up compared with those without FHG (3.71 ± 2.56 versus 1.87 ± 2.22, P < .001). In the subgroup analyses, FHG was associated with poor neurological outcome in the group without diabetes (3.74 ± 2.52 versus 1.81 ± 3.74, P < .001) but not with diabetes (3.64 ± 2.67 versus 2.30 ± 3.74, P= .11). Patients without diabetes who had FHG were older, had higher glucose on admission, higher prevalence of atrial fibrillation, cardioembolic stroke etiology and bleeding brain complications compared with the group with normal fasting glucose. After adjustment for potential confounders, fasting glucose (odds ratio [OR] 1.46; 95% CI 1.19-1.79, P < .001), age (OR 1.06; 95% CI 1.02-1.10, P = .001), successful reperfusion (OR 0.09; 95% CI 0.04-0.22, P < .001) and baseline NIHSS score (OR 1.18; 95% CI 1.08-1.29, P < .001) were predictors of mRS 3-6 at 3-month follow-up in the whole group. In the subgroup without diabetes, fasting glucose (OR 1.57; 95% CI 1.17-2.11, P = .002), age (OR 1.05; 95% CI 1.01-1.08, P = .008), successful reperfusion (OR 0.11; 95% CI 0.04-0.30, P < .001) and baseline NIHSS score (OR 1.14; 95% CI 1.04-1.26, P = .011) were independent predictors of unfavorable 3-month outcome.
Conclusions: Fasting glucose on the next day after MT in patients with acute ischemic stroke is an independent risk factor for worse 3-month outcome.
Keywords: Hyperglycemia; outcome; stroke; thrombectomy.
Copyright © 2020. Published by Elsevier Inc.
Similar articles
-
Clinical Outcome After Mechanical Thrombectomy in Patients with Diabetes with Major Ischemic Stroke of the Anterior Circulation.World Neurosurg. 2018 Dec;120:e212-e220. doi: 10.1016/j.wneu.2018.08.032. Epub 2018 Aug 16. World Neurosurg. 2018. PMID: 30121406
-
High Stress Hyperglycemia Ratio Predicts Poor Outcome after Mechanical Thrombectomy for Ischemic Stroke.J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1668-1673. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.022. Epub 2019 Mar 16. J Stroke Cerebrovasc Dis. 2019. PMID: 30890395
-
Impact of Glucose on Outcomes in Patients Treated With Mechanical Thrombectomy: A Post Hoc Analysis of the Solitaire Flow Restoration With the Intention for Thrombectomy Study.Stroke. 2016 Jan;47(1):120-7. doi: 10.1161/STROKEAHA.115.010753. Epub 2015 Dec 10. Stroke. 2016. PMID: 26658447 Clinical Trial.
-
Effects of Diabetes Mellitus and Admission Glucose in Patients Receiving Mechanical Thrombectomy: A Systematic Review and Meta-analysis.Neurocrit Care. 2018 Dec;29(3):426-434. doi: 10.1007/s12028-018-0562-4. Neurocrit Care. 2018. PMID: 29946761
-
Mothership versus drip and ship for thrombectomy in patients who had an acute stroke: a systematic review and meta-analysis.J Neurointerv Surg. 2019 Jan;11(1):14-19. doi: 10.1136/neurintsurg-2018-014249. Epub 2018 Oct 8. J Neurointerv Surg. 2019. PMID: 30297541
Cited by
-
Ischemic stroke and reperfusion therapies in diabetic patients.Neurol Sci. 2022 Jul;43(7):4335-4348. doi: 10.1007/s10072-022-05935-x. Epub 2022 Feb 11. Neurol Sci. 2022. PMID: 35146566
-
Association between CHADS2, CHA2DS2-VASc, ATRIA, and Essen Stroke Risk Scores and Unsuccessful Recanalization after Endovascular Thrombectomy in Acute Ischemic Stroke Patients.J Clin Med. 2022 Jan 5;11(1):274. doi: 10.3390/jcm11010274. J Clin Med. 2022. PMID: 35012015 Free PMC article.
-
C-Reactive Protein and White Blood Cell Count in Non-Infective Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.J Clin Med. 2021 Apr 10;10(8):1610. doi: 10.3390/jcm10081610. J Clin Med. 2021. PMID: 33920119 Free PMC article.
-
Association between hyperglycemia and unfavorable outcome in patients with successful thrombectomy for acute ischemic stroke: a single-center study.BMC Neurol. 2025 Aug 13;25(1):333. doi: 10.1186/s12883-025-04357-4. BMC Neurol. 2025. PMID: 40804609 Free PMC article.
-
Fasting Normoglycemia after Intravenous Thrombolysis Predicts Favorable Long-Term Outcome in Non-Diabetic Patients with Acute Ischemic Stroke.J Clin Med. 2021 Jul 6;10(14):3005. doi: 10.3390/jcm10143005. J Clin Med. 2021. PMID: 34300171 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical